Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × talquetamab × Clear all

NCT04634552 2026-03-17

MonumenTAL-1

Phase 2 Recruiting

510 enrolled 1 FDA

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms